More than 500,000 Coloradans are living with a brain injury, and about half will also be diagnosed with a mental health condition, according to the Brain Injury Association of Colorado. One program is ...

For many depression patients, relief means trying all sorts of different medications. But now, more people are discovering transcranial magnetic stimulation, a therapy for the brain.

While heat is often associated with reduced athletic performance and the dangers of heat stress, research increasingly shows that controlled heat exposure can provide powerful long-term health ...

The authors describe the scientific foundations of a study of gene therapy for hearing loss caused by damaging variants in the gene OTOF. Department of Otorhinolaryngology and Head and Neck Surgery, ...

UniQure needs to run another study to prove its gene therapy "actually helps people with Huntington's disease," a senior FDA official said. The official said UniQure is the "latest company to make a ...

Red light therapy can be a useful tool for recovery, as it increases blood flow and reduces inflammation. And while it’s not a substitute for a full recovery routine — according to our experts, things ...

Hair loss isn’t always dramatic. It can be incremental. You start noticing a bit more scalp in harsh bathroom lighting; a tiny bald spot when you tie your hair up in a ponytail. The shower drain is ...

You’ve seen the signs for months: the spiraling texts, the ill-timed meltdowns, the same painful story on repeat. You care about this person. You’re exhausted by this person. And you’re starting to ...

Just three months after further scaling back its support for the struggling hemophilia A gene therapy Roctavian, BioMarin is walking away altogether by pulling the treatment from the market. The move ...

TMS uses electromagnetic induction to stimulate neurons, similar to how a wireless charger transfers energy. The FDA has cleared TMS for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder ...

Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1/2 trial. The shuttered study, dubbed Lenticlair 1, failed to produce ...

A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...